NCATS will collaborate with federal agencies, academic researchers and the private sector in the Antiviral Program for Pandemics and apply its proficiency in drug discovery and development to accelerate antiviral development.
Christopher P. Austin, M.D., will step down as NCATS director on April 15, 2021. Deputy Director Joni L. Rutter, Ph.D., will serve as acting director while a national search for the new NCATS director is underway.
NCATS is committed to raising awareness about rare diseases and identifying treatments to address this urgent public health issue. The annual Rare Disease Day at NIH event held this year on March 1, offers an opportunity to advance this mission.
NCATS quickly pivoted many of its existing platforms, technologies and programs to address COVID-19 in March. The translational science approaches to COVID-19 similarly can speed solutions for many diseases and future pandemics.